KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Debt to Equity (2016 - 2026)

Zimmer Biomet Holdings has reported Debt to Equity over the past 18 years, most recently at $0.59 for Q1 2026.

  • For Q1 2026, Debt to Equity rose 1.83% year-over-year to $0.59; the TTM value through Mar 2026 reached $0.59, up 1.83%, while the annual FY2025 figure was $0.59, 19.0% up from the prior year.
  • Debt to Equity for Q1 2026 was $0.59 at Zimmer Biomet Holdings, roughly flat from $0.59 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.64 in Q3 2025 and troughed at $0.44 in Q3 2023.
  • A 5-year average of $0.51 and a median of $0.5 in 2022 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: dropped 20.97% in 2022 and later soared 32.01% in 2025.
  • Year by year, Debt to Equity stood at $0.47 in 2022, then dropped by 2.49% to $0.46 in 2023, then increased by 7.67% to $0.5 in 2024, then grew by 19.0% to $0.59 in 2025, then dropped by 0.45% to $0.59 in 2026.
  • Business Quant data shows Debt to Equity for ZBH at $0.59 in Q1 2026, $0.59 in Q4 2025, and $0.64 in Q3 2025.